Serum chitotriosidase enzyme activity in patients with Crimean-Congo hemorrhagic fever

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 12, 2009, Pages 1543-1547

  Kurt, Yasemin Gulcan ^a   Cayci, Tuncer ^a   Onguru, Pinar ^b   Akgul, E Ozgur ^a   Yaman, Halil ^a   Aydin, Ibrahim ^a   Bodur, Hurrem ^b   Turker, Turker ^a   Kurt, Ismail ^a   Cevik, M Aydin ^b   Erbil, M Kemal ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Chitotriosidase enzyme activity; Crimean congo hemorrhagic fever; Mortality

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHITOTRIOSIDASE; CREATINE KINASE; FIBRINOGEN; LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; MORTALITY; NAIRO VIRUS; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; THROMBOCYTE COUNT;

ADULT; CASE-CONTROL STUDIES; FEMALE; HEMORRHAGIC FEVER, CRIMEAN; HEXOSAMINIDASES; HUMANS; MALE; MIDDLE AGED;

EID: 73249152864     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.347     Document Type: Article

References (32)

1. Cagatay A, Kapmaz M, Karadeniz A, Basaran S, Yenerel M, Yavuz S, et al. Haemophagocytosis in a patient with Crimean Congo haemorrhagic fever. J Med Microbiol 2007;56:1126-1128
2. Chinikar S, Persson SM, Johansson M, Bladh L, Goya M, Houshmand B, et al. Genetic analysis of Crimean-Congo hemorrhagic fever virus in Iran. J Med Virol 2004;73: 404-411
3. Papa A, Papadimitriou E, Boźović B, Antoniadis A. Genetic characterization of the M RNA segment of a Balkan Crimean-Congo hemorrhagic fever virus strain. J Med Virol 2005;75:466-469
4. Mardani M, Jahromi MK, Naieni KH, Zeinali M. The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran. Clin Infect Dis 2003;36:1613-1618
5. Flick R, Flick K, Feldmann H, Elgh F. Reverse genetics for Crimean-Congo hemorrhagic fever virus. J Virol 2003;77: 5997-6006.
6. Vorou R, Pierroutsakos IN, Maltezou HC. Crimean-Congo hemorrhagic fever. Curr Opin Infect Dis 2007;20:495-500.
7. Rai MA, Khanani MR, Warraich HJ, Hayat A, Ali SH. Crimean-Congo hemorrhagic fever in Pakistan. J Med Virol 2008;80:1004-1006
8. Chinikar S, Goya MM, Shirzadi MR, Ghiasi SM, Mirahmadi R, Haeri A, et al. Surveillance and laboratory detection system of Crimean-Congo haemorrhagic fever in Iran. Transbound Emerg Dis 2008;55:200-204
9. Onguru P, Akgul EO, Akinci E, Yaman H, Kurt YG, Erbay A, et al. High serum levels of neopterin in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. J Infect 2008;56:366-370
10. Artieda M, Cenarro A, Gañán A, Jericó I, Gonzalvo C, Casado JM, et al. Serum chitotriosidase activity is increased in subjects with atherosclerosis disease. Arterioscler Thromb Vasc Biol 2003;23:1645-1652
11. Artieda M, Cenarro A, Gañ án A, Lukic A, Moreno E, Puzo J, et al. Serum chitotriosidase activity, a marker of activated macrophages, predicts new cardiovascular events independently of C-reactive protein. Cardiology 2007; 108:297-306.
12. Hall AJ, Morroll S, Tighe P, Götz F, Falcone FH. Human chitotriosidase is expressed in the eye and lacrimal gland and has an antimicrobial spectrum different from lysozyme. Microbes Infect 2008;10:69-78.
13. Cai CL, Zhou X, Zhao L, Yao XJ, Tu JC, Zheng F, et al. Optical detection of plasma chitotriosidase activity in healthy Chinese children using fluorescence spectrophotometry. Clin Chim Acta 2007;379:134-138
14. Bargagli E, Margollicci M, Luddi A, Nikiforakis N, Perari MG, Grosso S, et al. Chitotriosidase activity in patients with interstitial lung diseases. Respir Med 2007;101: 2176-2181 (Pubitemid 47324238)
15. Boot RG, Renkema GH, Verhoek M, Strijland A, Bliek J, de Meulemeester TM, et al. The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem 1998;273:25680-25685
16. Tunc T, Kul M, Yaman H, Demirkaya E, Saldir M, Kurt I, et al. Chitotriosidase activity in human milk from mothers of premature and full-term infants during the first month of lactation. Clin Biochem 2008;41:693-696
17. Labadaridis I, Dimitriou E, Theodorakis M, Kafalidis G, Velegraki A, Michelakakis H. Chitotriosidase in neonates with fungal and bacterial infections. Arch Dis Child Fetal Neonatal Ed 2005;90:F531-2.
18. Boot RG, Renkema GH, Strijland A, van Zonneveld AJ, Aerts JM. Cloning of a cDNA encoding chitotriosidase, a human chitinase produced by macrophages. J Biol Chem 1995;270:26252-26256
19. Barone R, Di Gregorio F, Romeo MA, Schiliro G, Pavone L. Plasma chitotriosidase activity in patients with betathalassemia. Blood Cells Mol Dis 1999;25:1-8.
20. Barone R, Simpore J, Malaguarnera L, Pignatelli S, Musumeci S. Plasma chitotriosidase activity in acute Plasmodium falciparum malaria. Clin Chim Acta 2003; 331:79-85. (Pubitemid 36412028)
21. Guo Y, He W, Boer AM, Wevers RA, de Bruijn AM, Groener JE, et al. Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J Inherit Metab Dis 1995;18:717-722
22. Hollak CE, van Weely S, van Oers MH, Aerts JM. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 1994;93:1288-1292
23. Labadaridis J, Dimitriou E, Costalos C, Aerts J, van Weely S, Donker-Koopman WE, et al. Serial chitotriosidase activity estimations in neonatal systemic candidiasis. Acta Paediatr 1998;87:605.
24. Overdijk B, Van Steijn GJ, Odds FC. Distribution of chitinase in guinea pig tissues and increases in levels of this enzyme after systemic infection with Aspergillus fumigatus. Microbiology 1999;145:259-269
25. Kamaya T. Lytic action of lysozyme on Candida albicans. Mycopathol Mycol Appl 1970;42:197-207.
26. Marquis G, Montplaisir S, Garzon S, Strykowski H, Auger P. Fungitoxicity of muramidase. Ultrastructural damage to Candida albicans. Lab Invest 1982;46:627-636
27. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989;11:794-800.
28. Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H, et al. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol 2005;54:385-389
29. Karti SS, Odabasi Z, Korten V, Yilmaz M, Sonmez M, Caylan R, et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis 2004;10:1379-1384
30. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect 2006;12:551-554
31. Alavi-Naini R, Moghtaderi A, Koohpayeh HR, Sharifi-Mood B, Naderi M, Metanat M, et al. Crimean-Congo hemorrhagic fever in Southeast of Iran. J Infect 2006; 52:378-382
32. Cevik MA, Erbay A, Bodur H, Gülderen E, Baş tuǧ A, Kubar A, et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 2008;12:374-379